Lupus nephritis is diagnosed through a combination of urine tests, blood work, and in most cases, a kidney biopsy to confirm the diagnosis and determine its severity. The process typically begins when routine lab work in someone with lupus reveals protein in the urine exceeding 0.5 grams per day, blood cells in the urine, or a rise in serum creatinine suggesting the kidneys are losing function.
Symptoms That Trigger a Workup
Many people with lupus nephritis don’t feel noticeably sick in the early stages. Kidney damage can develop silently, which is why regular urine and blood screening matters for anyone living with lupus. When symptoms do appear, the most common ones are foamy urine (a sign of excess protein leaking through the kidneys), swelling in the legs, feet, ankles, hands, or face, and high blood pressure that’s new or harder to control than usual.
Because these signs overlap with many other conditions, they don’t confirm lupus nephritis on their own. But in someone already diagnosed with systemic lupus, they’re a strong signal that the kidneys need closer evaluation.
Urine Tests: The First Step
The initial screening tool is a urinalysis, often paired with a spot urine protein-to-creatinine ratio or a 24-hour urine collection. Doctors look for two key findings: proteinuria (protein spilling into the urine) and hematuria (red blood cells in the urine). The clinical threshold that raises concern is proteinuria above 0.5 grams per day and five or more red blood cells per high-power field on microscopy, particularly if those red blood cells appear misshapen, which suggests they’re coming from damaged filtering units inside the kidney rather than from the bladder or urinary tract.
The presence of cellular casts in the urine is another important clue. These are tiny tube-shaped clumps of cells that form inside the kidney’s filtering tubules and get flushed out. Finding them points strongly toward active kidney inflammation.
Even lower levels of protein loss deserve attention. A study of 151 lupus patients with proteinuria between 0.2 and 0.5 grams per day found that half of them progressed past the 0.5-gram threshold within one to two years. So borderline results usually lead to closer monitoring rather than reassurance.
Blood Tests That Reflect Kidney Involvement
Several blood markers help piece together the diagnosis. Serum creatinine and estimated glomerular filtration rate (eGFR) measure how well your kidneys are filtering waste. A rising creatinine or falling eGFR signals declining kidney function.
Beyond kidney-specific labs, two sets of immune markers are especially useful:
- Complement levels (C3 and C4). These proteins are part of the immune system, and lupus consumes them during active flares. Low levels, generally below 60 for C3 and below 15 for C4, are common in active lupus nephritis. Falling complement levels can sometimes signal a flare before symptoms appear.
- Anti-dsDNA antibodies. About 80% of people with active, untreated lupus test positive for these antibodies. Higher titers correlate with more active disease, and tracking changes over time helps gauge whether kidney inflammation is worsening or improving.
A positive antinuclear antibody (ANA) test is considered a prerequisite for any lupus diagnosis under current classification criteria. If you’ve already been diagnosed with lupus, this test was almost certainly positive at some point. It doesn’t specifically indicate kidney disease but confirms the underlying autoimmune process.
Why a Kidney Biopsy Is Usually Needed
Blood and urine tests can strongly suggest lupus nephritis, but they can’t tell your doctor exactly what’s happening inside the kidney tissue. A kidney biopsy is the definitive diagnostic step. It’s typically recommended when proteinuria exceeds 0.5 grams per day, when there are more than five red blood cells per high-power field in the urine, or when kidney function is declining without a clear explanation.
During the procedure, a thin needle is guided into the kidney, usually with ultrasound to pinpoint the right spot, and a small tissue sample is removed. The sample is examined under a microscope in three different ways: standard light microscopy, immunofluorescence (which highlights immune deposits using fluorescent dyes), and electron microscopy (which reveals ultrastructural details invisible at lower magnification).
The Six Classes of Lupus Nephritis
The biopsy results are classified using the International Society of Nephrology/Renal Pathology Society (ISN/RPS) system, which divides lupus nephritis into six classes based on the pattern and severity of damage:
- Class I (minimal mesangial): Immune deposits are present but visible only under electron microscopy. The kidney looks normal under a standard microscope.
- Class II (mesangial proliferative): Immune deposits cause mild expansion or increased cell growth in the mesangium, the kidney’s supportive tissue between filtering capillaries.
- Class III (focal): Inflammation affects fewer than 50% of the kidney’s filtering units (glomeruli), with immune deposits forming beneath the inner lining of capillaries.
- Class IV (diffuse): The most severe and common form. Inflammation involves 50% or more of glomeruli, often with widespread immune deposits. This class can include a distinctive “wire loop” pattern visible under the microscope.
- Class V (membranous): Immune deposits form beneath the outer surface of capillary walls, causing thickening. This class often presents with heavy protein loss.
- Class VI (advanced sclerosing): More than 90% of glomeruli are scarred. This represents end-stage damage with little active inflammation left to treat.
The class matters enormously for treatment decisions. Classes III and IV require aggressive immunosuppressive therapy, while Class II may be managed more conservatively. Class V can appear alone or overlap with III or IV, changing the approach. Without a biopsy, doctors would be guessing at severity.
The Role of Imaging
A kidney ultrasound is often performed during the diagnostic process, though its contribution is limited compared with lab work and biopsy. Ultrasound can detect changes in kidney size and the brightness of the kidney’s outer layer (cortical echogenicity), and one study found it was 95% sensitive in detecting lupus nephritis based on these features. Its primary practical value, however, is guiding the biopsy needle and ruling out other structural problems like blockages in the urinary tract. It doesn’t replace biopsy for classification or treatment planning.
Conditions That Can Look Similar
Part of the diagnostic process involves ruling out other causes of kidney problems that can mimic or coexist with lupus nephritis. These include IgA nephropathy, vasculitis affecting small blood vessels, membranous kidney disease unrelated to lupus, kidney injury from medications, and inflammation of the kidney’s tubules rather than its filtering units. Other autoimmune conditions like Sjögren syndrome and polyarteritis nodosa can also cause overlapping kidney findings. The biopsy is often what definitively separates lupus nephritis from these look-alikes, because the pattern and location of immune deposits under the microscope are distinctive.
How Diagnosis Fits Into Classification Criteria
Under the 2019 EULAR/ACR classification system for lupus, kidney involvement carries significant diagnostic weight. Proteinuria above 0.5 grams per day earns 4 points toward a lupus diagnosis. A biopsy showing Class II or V nephritis earns 8 points, and Class III or IV earns 10 points, the highest weight of any single criterion in the system. A total of 10 points (across all organ systems and immune markers) is needed for classification, so biopsy-confirmed lupus nephritis alone can meet or nearly meet the threshold. The 2024 KDIGO guidelines for lupus nephritis management continue to emphasize biopsy as central to both diagnosis and treatment planning.